Skip to main content
Log in

Insulin and C-peptide plasma levels in patients with severe chronic pancreatitis and fasting normoglycemia

  • Original Articles
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

The aim of the present study was to evaluate insulin secretion by the pancreatic B cell in a group of patients with severe chronic pancreatitis and without overt diabetes. For this purpose we have measured plasma insulin and C-peptide peripheral levels in the fasting state and after a 100-g oral glucose load in 10 patients with severe chronic pancreatitis and fasting normoglycemia, and in 10 sex-, age-, and weight-matched healthy controls. As compared to normal subjects, patients with chronic pancreatitis showed: (1) significantly higher plasma glucose levels after oral glucose load (area under the plasma glucose curve 1708±142 vs 1208±47 mmol/liter × 240 min, P < 0.005); (2) plasma insulin levels significantly higher at fasting (0.11±0.008 vs 0.08±0.005 nmol/liter, P < 0.01) but not after oral glucose administration (area under the plasma insulin curve 79±12 vs 88 ±16 nmol/liter × 240 min); (3) significantly lower plasma C-peptide concentrations both in the fasting state (0.15±0.01 vs 0.54±0.05 nmol/liter, P<0.001) and after oral glucose load (area under the plasma C-peptide curve 211±30 vs 325±37 nmol/liter × 240 min, P<0.05). The finding of diminished plasma C-peptide levels suggests that chronic pancreatitis is associated with an impaired B-cell function even in the absence of overt diabetes. The increased or unchanged plasma insulin levels in spite of decreased plasma C-peptide concentrations indicate that in chronic pancreatitis insulin metabolism is reduced, most likely within the liver.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Anderson MF, Davison, SHH, Dick AP, Hales CN, Owens J: Plasma insulin in pancreatic disease. Gut 11:524–531, 1970

    PubMed  Google Scholar 

  2. Grabner W, Phillip J, Strigl P: The diagnostic value of oral glucose tolerance test and combined B-cell stimulation in chronic pancreatitis. Am J Dig Dis 18:1055–1060, 1973

    PubMed  Google Scholar 

  3. Seligson U, Cho JW, Nygren A, Reichard P: Is glucose intolerance after pancreatitis related to pancreatic tissue damage? Acta Med Scand 213:119–122, 1983

    PubMed  Google Scholar 

  4. Field JB: Extraction of insulin by liver. Annu Rev Med 24:309–314, 1973

    PubMed  Google Scholar 

  5. Johnston DG, Alberti KGMM, Faber OK, Binder C, Wright R: Hyperinsulinism of hepatic cirrhosis: diminished degradation or hypersecretion? Lancet 1:10–12, 1977

    PubMed  Google Scholar 

  6. Iwasaki Y, Ohkubo A, Kajinuma H, Akanuma Y, Kosaka K: Degradation and secretion of insulin in hepatic cirrhosis. J Clin Endocrinol Metab 47:774–779, 1978

    PubMed  Google Scholar 

  7. Bonora E, Coscelli C, Orioli S, Cambi R, Buzzelli G, Gentilini P, Butturini U: Hyperinsulinemia of chronic active hepatitis: Impaired insulin removal rather than pancreatic hypersecretion. Horm Metab Res 16:111–114, 1984

    PubMed  Google Scholar 

  8. Horwitz DL, Starr JI, Mako ME, Blackard WG, Rubenstein AH: Proinsulin, insulin, and C-peptide concentration in human portal and peripheral blood. J Clin Invest 55:1278–1283, 1975

    PubMed  Google Scholar 

  9. Polonsky K, Jaspan J, Pugh W, Cohen D, Schneider M, Schwartz T, Moossa AR, Tager H, Rubenstein AH: Metabolism of C-peptide in the dog.In vivo demonstration of the absence of hepatic extraction. J Clin Invest 72:1114–1123, 1983

    PubMed  Google Scholar 

  10. Bratusch-Marrain P, Waldhausl W, Gasic S, Hofer A: Hepatic disposal of biosynthetic human insulin and porcine C-peptide in humans. Metabolism 33:151–157, 1984

    PubMed  Google Scholar 

  11. Katz AI, Rubenstein AH: Metabolism of proinsulin, insulin, and C-peptide in the rat. J Clin Invest 52:1113–1121, 1973

    PubMed  Google Scholar 

  12. Polonsky KS, Pugh W, Jaspan JB, Cohen DM, Karrison T, Tager HS, Rubenstein AH: C-peptide and insulin secretion. Relationship between peripheral concentrations of C-peptide and insulin and their secretion rates in the dog. J Clin Invest 74:1821–1829, 1984

    PubMed  Google Scholar 

  13. Faber OK, Hagen C, Binder C, Markussen J, Naithani J, Blix PM, Kuzuya H, Horwitz DL, Rubenstein AH, Rossing N: Kinetics of human connecting peptide in normal and diabetic subjects. J Clin Invest 62:197–203, 1978

    PubMed  Google Scholar 

  14. Polonsky KS, Licinio-Paixao J, Given BD, Pugh W, Rue P, Galloway J, Karrison T, Frank B: Use of biosynthetic human C-peptide in the measurement of insulin secretion rates in normal volunteers and in type I diabetic patients. J Clin Invest 77:98–105, 1986

    PubMed  Google Scholar 

  15. Licinio-Paixao J, Polonsky KS, Given BD, Pugh W, Ostrega D, Frank BF, Rubenstein AH: Ingestion of a mixed meal does not affect the metabolic clearance rate of biosynthetic human C-peptide. J Clin Endocrinol Metab 63:401–403, 1986

    PubMed  Google Scholar 

  16. Sando H, Lee YS, Iwamoto Y, Ikeuchi M, Kosaka K: Isoproterenol-stimulated C-peptide and insulin secretion in diabetic and nonobese normal subjects: Decreased hepatic extraction of endogenous insulin in diabetes. J Clin Endocrinol Metab 51:1143–1149, 1980

    PubMed  Google Scholar 

  17. Faber OK, Christensen K, Kehlet H, Madsbad S, Binder C: Decreased insulin removal contributes to hyperinsulinemia in obesity. J Clin Endocrinol Metab 53:618–621, 1981

    PubMed  Google Scholar 

  18. Madsbad S, Kehlet H, Hilsted J, Tronier B: Discrepancy between plasma C-peptide and insulin response to oral and intravenous glucose. Diabetes 32:436–438, 1983

    PubMed  Google Scholar 

  19. Bonora E, Zavaroni I, Coscelli C, Butturini U: Decreased hepatic insulin extraction in subjects with mild glucose intolerance. Metabolism 32:438–446, 1983

    PubMed  Google Scholar 

  20. Bonora E, Zavaroni I, Bruschi F, Alpi O, Pezzarossa A, Guerra L, Dall'Aglio E, Coscelli C, Butturini U: Peripheral hyperinsulinemia of simple obesity: pancreatic hypersecretion or impaired insulin metabolism? J Clin Endocrinol Metab 59:1121–1127, 1984

    PubMed  Google Scholar 

  21. Lesi C, Scandellari A, Cucci AM, Franceschi F, Matacena C, Malaguti P: Changes in serum pancreatic enzymes after hormonal stimulation in chronic pancreatitis. Dig Dis Sci 30:552–556, 1985

    PubMed  Google Scholar 

  22. Hales CN, Randle PJ: Immunoassay of insulin with insulin-antibody precipitate. Biochem J 88:137–146, 1963

    PubMed  Google Scholar 

  23. Kaneko T, Oka H, Munemura M, Oda T, Yamashita K, Suzuki S, Yanaihara N, Hashimoto T, Yanaihara C: Radioimmunoassay of human proinsulin C-peptide using synthetic human connecting peptide. Endocrinol Jpn 21:141–145, 1974

    PubMed  Google Scholar 

  24. Tallaride RJ, Murray RB: Manual of Pharmacologic Calculations. Berlin, Springer-Verlag, 1981, pp 47–49

    Google Scholar 

  25. Joffe BI, Bank S, Jackson WPU, Keller P, O'Reilly TG, Vinik AI: Insulin reserve in patients with chronic pancreatitis. Lancet 2:121–124, 1968

    Google Scholar 

  26. Ohlsen P: Endocrine and exocrine pancreatic function in pancreatitis. Acta Med Scand Suppl 484:7–99, 1968

    Google Scholar 

  27. Kalk WJ, Vinik AI, Bank S, Keller P, Jackson WPU: Selective loss of beta cell response to glucose in chronic pancreatitis. Horm Metab Res 6:95–98, 1974

    PubMed  Google Scholar 

  28. Peters N, Dick AP, Hales CN, Orrell DH, Sarner M: Exocrine and endocrine pancreatic function in diabetes mellitus and chronic pancreatitis. Gut 7:277–281, 1966

    Google Scholar 

  29. Duckworth WC, Solomon SS, Jallepalli P, Iyer R, Bobal MA: Hormonal response to intravenous glucose and arginine in patients with pancreatitis. Horm Res 17:65–73, 1983

    PubMed  Google Scholar 

  30. Bank S, Marks IN, Vinik AI: Clinical and hormonal aspects of pancreatic diabetes. Am J Gastroenterol 64:13–22, 1975

    PubMed  Google Scholar 

  31. Keller P, Bank S, Jackson WPU, Marks IN, O'Reilly IG: Plasma insulin levels in “pancreatic diabetes”. Lancet 2:1211–1213, 1965

    PubMed  Google Scholar 

  32. McKiddie MT, Buchanan KD, McBain GC, Bell G: The insulin response to glucose in patients with pancreatic disease. Postgrad Med J 45:726–730, 1969

    PubMed  Google Scholar 

  33. Goldstein BJ, Livingston JN: Insulin degradation by insulin target cells. Metabolism 30:825–835, 1981

    Google Scholar 

  34. Bonora E, Orioli S, Coscelli C, Buzzelli G, Butturini U, Gentilini P: Glucose tolerance, insulin secretion and insulin removal in chronic persistant hepatitis. Horm Metab Res 16:449–450, 1984

    PubMed  Google Scholar 

  35. Bank S.: Chronic pancreatitis: Clinical features and medical management. Am J Gastroenterol 81:153–167, 1987

    Google Scholar 

  36. Polonsky KS, Rubenstein AH: C-peptide as a measure of the secretion and hepatic extraction of insulin. Pitfalls and limitations. Diabetes 33:486–494, 1984

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Supported by grant 85.00775.04 from C.N.R., Rome, Italy.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bonora, E., Rizzi, C., Lesi, C. et al. Insulin and C-peptide plasma levels in patients with severe chronic pancreatitis and fasting normoglycemia. Digest Dis Sci 33, 732–736 (1988). https://doi.org/10.1007/BF01540438

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01540438

Key words

Navigation